Wealthcare Advisory Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wealthcare Advisory Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$224K	Sell	822 -69	-8%	-$17.9K	﹤0.01%	1016
2026 Q2	$221K	Buy	+891	New	+$192K	﹤0.01%	1009
2021 Q2	–	Sell	-478	Closed	-$77K	–	958
2021 Q1	$77K	Buy	+478	New	+$81.8K	0.01%	747
2020 Q2	–	Sell	-954	Closed	-$125K	–	652
2020 Q1	$125K	Buy	954 +390	+69%	+$55.6K	0.02%	332
2019 Q4	$84K	Sell	564 -90	-14%	-$12.4K	0.01%	435
2019 Q3	$81K	Hold	654	–	–	0.01%	439
2019 Q2	$92K	Hold	654	–	–	0.01%	392
2019 Q1	$99K	Hold	654	–	–	0.02%	339
2018 Q4	$81K	Sell	654 -39	-6%	-$5.33K	0.02%	340
2018 Q3	$110K	Buy	693 +173	+33%	+$26.2K	0.02%	318
2018 Q2	$73K	Buy	520 +43	+9%	+$5.9K	0.01%	387
2018 Q1	$63K	Hold	477	–	–	0.01%	358
2017 Q4	$59K	Hold	477	–	–	0.02%	345
2017 Q3	$59K	Buy	+477	New	+$56.5K	0.02%	283

Other funds holding FBT

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

Wealthcare Advisory Partners's FBT Position: Q3 2026 in Review

Wealthcare Advisory Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.7% in Q3 2026, selling an estimated $17.9K and leaving 822 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Wealthcare Advisory Partners first reported a position in FBT in Q3 2017 and has held it in 14 quarters since. 144 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Wealthcare Advisory Partners held 822 shares of First Trust NYSE Arca Biotechnology Index Fund worth $224K as of Q3 2026.
Wealthcare Advisory Partners sold 69 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $17.9K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q3 2026, its #1016 holding.
Wealthcare Advisory Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and has held it in 14 quarters since.
144 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q3 2026, filed 21 Oct 2026.